Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02389881 · ClinicalTrials.gov registry record · Phase 1
Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants
A Phase 1 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT02389881 is a Phase 1 study that has completed, run by Takeda. The registered enrollment target is 40 participants.
The verdict
NCT02389881, a Phase 1 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of multiple doses of TAK-058 in healthy non-elderly and elderly participants.
Interventions
- DRUG TAK-058
- DRUG TAK-058 Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02389881
The ClinicalTrials.gov registry entry for NCT02389881 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TAK-058 is the first listed.
NCT02389881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02389881 about?
NCT02389881 is a clinical study titled "Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants". The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of multiple doses of TAK-058 in healthy non-elderly and elderly participants.
What is the current status of trial NCT02389881?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2015-02. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02389881?
The interventions under investigation include: TAK-058 (DRUG), TAK-058 Placebo (DRUG).
Who is sponsoring clinical trial NCT02389881?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.